{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,30]],"date-time":"2026-03-30T17:53:16Z","timestamp":1774893196498,"version":"3.50.1"},"reference-count":40,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2018,5,1]],"date-time":"2018-05-01T00:00:00Z","timestamp":1525132800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100000874","name":"Brain and Behavior Research Foundation","doi-asserted-by":"publisher","award":["17699"],"award-info":[{"award-number":["17699"]}],"id":[{"id":"10.13039\/100000874","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Physiology &amp; Behavior"],"published-print":{"date-parts":[[2018,5]]},"DOI":"10.1016\/j.physbeh.2018.03.008","type":"journal-article","created":{"date-parts":[[2018,3,8]],"date-time":"2018-03-08T01:55:35Z","timestamp":1520474135000},"page":"86-91","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"special_numbering":"C","title":["Effects of intranasal oxytocin on satiety signaling in people with schizophrenia"],"prefix":"10.1016","volume":"189","author":[{"given":"Kimberly R.","family":"Warren","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Heidi J.","family":"Wehring","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fang","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Robert P.","family":"McMahon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shuo","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Charlene","family":"Chester","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2176-518X","authenticated-orcid":false,"given":"Deanna L.","family":"Kelly","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.physbeh.2018.03.008_bb0005","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1111\/acps.12445","article-title":"Weight gain and obesity in schizophrenia: epidemiology, pathobiology, and management","volume":"132","author":"Manu","year":"2015","journal-title":"Acta Psychiatr. Scand."},{"key":"10.1016\/j.physbeh.2018.03.008_bb0010","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/j.genhosppsych.2015.03.004","article-title":"Review of the evidence: prevalence of medical conditions in the United States population with serious mental illness","volume":"37","author":"Janssen","year":"2015","journal-title":"Gen. Hosp. Psychiatry"},{"key":"10.1016\/j.physbeh.2018.03.008_bb0015","series-title":"Healthcare","article-title":"Obesity and serious mental ill health: A critical review of the literature","author":"Bradshaw","year":"2014"},{"key":"10.1016\/j.physbeh.2018.03.008_bb0020","first-page":"96","article-title":"Interventions to address medical conditions and health-risk behaviors among persons with serious mental illness: a comprehensive review","volume":"42","author":"McGinty","year":"2016","journal-title":"Schizophr. Bull."},{"key":"10.1016\/j.physbeh.2018.03.008_bb0025","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1016\/j.psc.2009.08.003","article-title":"Management of schizophrenia with obesity, metabolic, and endocrinological disorders","volume":"32","author":"Monteleone","year":"2009","journal-title":"Psychiatr. Clin. North Am."},{"key":"10.1016\/j.physbeh.2018.03.008_bb0030","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0094112","article-title":"Almost all antipsychotics result in weight gain: a meta-analysis","volume":"9","author":"Bak","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.physbeh.2018.03.008_bb0035","doi-asserted-by":"crossref","first-page":"662","DOI":"10.1097\/jcp.0b013e31815a8872","article-title":"Clozapine and olanzapine are associated with food craving and binge eating: results from a randomized double-blind study","volume":"27","author":"Kluge","year":"2007","journal-title":"J. Clin. Psychopharmacol."},{"key":"10.1016\/j.physbeh.2018.03.008_bb0040","doi-asserted-by":"crossref","first-page":"1385","DOI":"10.1093\/schbul\/sbu030","article-title":"Pharmacological strategies to counteract antipsychotic-induced weight gain and metabolic adverse effects in schizophrenia: a systematic review and meta-analysis","volume":"40","author":"Mizuno","year":"2014","journal-title":"Schizophr. Bull."},{"key":"10.1016\/j.physbeh.2018.03.008_bb0045","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1093\/schbul\/sbp116","article-title":"The 2009 schizophrenia PORT psychopharmacological treatment recommendations and summary statements","volume":"36","author":"Buchanan","year":"2010","journal-title":"Schizophr. Bull."},{"key":"10.1016\/j.physbeh.2018.03.008_bb0050","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1677\/joe.0.0670461","article-title":"Distribution of oxytocin and vasopressin in the rat supraoptic and paraventricular nucleus","volume":"67","author":"Swaab","year":"1975","journal-title":"J. Endocrinol."},{"key":"10.1016\/j.physbeh.2018.03.008_bb0055","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1016\/j.numecd.2007.06.004","article-title":"Neuroendocrine control of food intake","volume":"18","author":"Valassi","year":"2008","journal-title":"Nutr. Metab. Cardiovasc. Dis."},{"key":"10.1016\/j.physbeh.2018.03.008_bb0060","first-page":"R800","article-title":"Medial nucleus tractus solitarius oxytocin receptor signaling and food intake control: the role of gastrointestinal satiation signal processing","volume":"308","author":"Ong","year":"2015","journal-title":"Am. J. Phys. Regul. Integr. Comp. Phys."},{"key":"10.1016\/j.physbeh.2018.03.008_bb0065","first-page":"R87","article-title":"Evidence that paraventricular nucleus oxytocin neurons link hypothalamic leptin action to caudal brain stem nuclei controlling meal size","volume":"287","author":"Blevins","year":"2004","journal-title":"Am. J. Phys. Regul. Integr. Comp. Phys."},{"key":"10.1016\/j.physbeh.2018.03.008_bb0070","doi-asserted-by":"crossref","first-page":"65","DOI":"10.3389\/fendo.2015.00065","article-title":"Central oxytocin and food intake: focus on macronutrient-driven reward","volume":"6","author":"Klockars","year":"2015","journal-title":"Front Endocrinol (Lausanne)"},{"key":"10.1016\/j.physbeh.2018.03.008_bb0075","doi-asserted-by":"crossref","first-page":"980","DOI":"10.1038\/oby.2009.12","article-title":"Low sympathetic tone and obese phenotype in oxytocin-deficient mice","volume":"17","author":"Camerino","year":"2009","journal-title":"Obesity (Silver Spring)"},{"key":"10.1016\/j.physbeh.2018.03.008_bb0080","first-page":"R640","article-title":"Chronic CNS oxytocin signaling preferentially induces fat loss in high-fat diet-fed rats by enhancing satiety responses and increasing lipid utilization","volume":"310","author":"Blevins","year":"2016","journal-title":"Am. J. Phys. Regul. Integr. Comp. Phys."},{"key":"10.1016\/j.physbeh.2018.03.008_bb0085","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1097\/MED.0000000000000351","article-title":"Oxytocin and potential benefits for obesity treatment","volume":"24","author":"Olszewski","year":"2017","journal-title":"Curr. Opin. Endocrinol. Diab. Obes."},{"key":"10.1016\/j.physbeh.2018.03.008_bb0090","doi-asserted-by":"crossref","first-page":"1243","DOI":"10.1002\/ajmg.a.38160","article-title":"Oxytocin treatment in children with Prader-Willi syndrome: a double-blind, placebo-controlled, crossover study","volume":"173","author":"Miller","year":"2017","journal-title":"Am. J. Med. Genet. A"},{"key":"10.1016\/j.physbeh.2018.03.008_bb0095","doi-asserted-by":"crossref","first-page":"812","DOI":"10.2466\/pr0.1962.10.3.799","article-title":"The brief psychiatric rating scale","volume":"10","author":"Overall","year":"1962","journal-title":"Psychol. Rep."},{"key":"10.1016\/j.physbeh.2018.03.008_bb0100","series-title":"Scale for the Assessment of Negative Symptoms (SANS) Negative Symptoms (SANS)","author":"Andreasen","year":"1983"},{"key":"10.1016\/j.physbeh.2018.03.008_bb0105","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1016\/j.schres.2013.11.013","article-title":"Converting positive and negative symptom scores between PANSS and SAPS\/SANS","volume":"152","author":"Van Erp","year":"2014","journal-title":"Schizophr. Res."},{"key":"10.1016\/j.physbeh.2018.03.008_bb0110","series-title":"ECDEU Assessment Manual for Psychopharmacology, Revised (DHEW Publication No. ADM 76-338)","author":"Guy","year":"1976"},{"key":"10.1016\/j.physbeh.2018.03.008_bb0115","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1192\/S0007125000292581","article-title":"Assessing depression in schizophrenia: the Calgary depression scale","author":"Addington","year":"1993","journal-title":"Br. J. Psychiatry Suppl."},{"key":"10.1016\/j.physbeh.2018.03.008_bb0120","doi-asserted-by":"crossref","first-page":"385","DOI":"10.2307\/2136404","article-title":"A global measure of perceived stress","volume":"24","author":"Cohen","year":"1983","journal-title":"J. Health Soc. Behav."},{"key":"10.1016\/j.physbeh.2018.03.008_bb0125","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1002\/hup.2343","article-title":"Oxytocin influences avoidant reactions to social threat in adults with borderline personality disorder","volume":"28","author":"Br\u00fcne","year":"2013","journal-title":"Hum. Psychopharmacol. Clin. Exp."},{"key":"10.1016\/j.physbeh.2018.03.008_bb0130","doi-asserted-by":"crossref","first-page":"950","DOI":"10.1002\/oby.21069","article-title":"Oxytocin reduces caloric intake in men","volume":"23","author":"Lawson","year":"2015","journal-title":"Obesity"},{"key":"10.1016\/j.physbeh.2018.03.008_bb0135","doi-asserted-by":"crossref","first-page":"11489","DOI":"10.1523\/JNEUROSCI.3984-05.2005","article-title":"Oxytocin modulates neural circuitry for social cognition and fear in humans","volume":"25","author":"Kirsch","year":"2005","journal-title":"J. Neurosci."},{"key":"10.1016\/j.physbeh.2018.03.008_bb0140","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1038\/nature03701","article-title":"Oxytocin increases trust in humans","volume":"435","author":"Kosfeld","year":"2005","journal-title":"Nature"},{"key":"10.1016\/j.physbeh.2018.03.008_bb0145","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/0149-7634(84)90028-9","article-title":"Satiating efficiency and a strategy for conducting food loading experiments","volume":"8","author":"Kissileff","year":"1984","journal-title":"Neurosci. Biobehav. Rev."},{"key":"10.1016\/j.physbeh.2018.03.008_bb0150","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1111\/j.1753-4887.1986.tb07593.x","article-title":"Sensory-specific satiety","volume":"44","author":"Rolls","year":"1986","journal-title":"Nutr. Rev."},{"key":"10.1016\/j.physbeh.2018.03.008_bb0155","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1097\/00005537-199603000-00021","article-title":"Development of the 12-item cross-cultural smell identification test (CC-SIT)","volume":"106","author":"Doty","year":"1996","journal-title":"Laryngoscope"},{"key":"10.1016\/j.physbeh.2018.03.008_bb0160","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/S0165-1781(03)00194-X","article-title":"A brief smell identification test discriminates between deficit and non-deficit schizophrenia","volume":"120","author":"Goudsmit","year":"2003","journal-title":"Psychiatry Res."},{"key":"10.1016\/j.physbeh.2018.03.008_bb0165","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1196\/annals.1384.006","article-title":"Oxytocin: behavioral associations and potential as a salivary biomarker","volume":"1098","author":"Carter","year":"2007","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"10.1016\/j.physbeh.2018.03.008_bb0170","doi-asserted-by":"crossref","first-page":"3595","DOI":"10.1080\/03610929008830400","article-title":"A class of invariant consistent tests for multivariate normality","volume":"19","author":"Henze","year":"1990","journal-title":"Commun. Stat. Theory Method."},{"key":"10.1016\/j.physbeh.2018.03.008_bb0175","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/0031-9384(83)90030-6","article-title":"Effects of sweetness perception and caloric value of a preload on short term intake","volume":"30","author":"Brala","year":"1983","journal-title":"Physiol. Behav."},{"key":"10.1016\/j.physbeh.2018.03.008_bb0180","doi-asserted-by":"crossref","first-page":"T83","DOI":"10.1530\/JOE-14-0358","article-title":"20 years of leptin: role of leptin in energy homeostasis in humans","volume":"223","author":"Rosenbaum","year":"2014","journal-title":"J. Endocrinol."},{"key":"10.1016\/j.physbeh.2018.03.008_bb0185","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1016\/j.psyneuen.2015.09.026","article-title":"Are leptin levels increased among people with schizophrenia versus controls? A systematic review and comparative meta-analysis","volume":"63","author":"Stubbs","year":"2016","journal-title":"Psychoneuroendocrinology"},{"key":"10.1016\/j.physbeh.2018.03.008_bb0190","first-page":"S26","article-title":"Antipsychotic-induced changes in blood levels of leptin in schizophrenia: a meta-analysis","volume":"60","author":"Potvin","year":"2015","journal-title":"Can. J. Psychiatr."},{"key":"10.1016\/j.physbeh.2018.03.008_bb0195","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/j.psyneuen.2014.08.017","article-title":"Serum leptin and its relationship with psychopathology in schizophrenia","volume":"50","author":"Nurjono","year":"2014","journal-title":"Psychoneuroendocrinology"},{"key":"10.1016\/j.physbeh.2018.03.008_bb0200","doi-asserted-by":"crossref","first-page":"119","DOI":"10.3389\/fendo.2015.00119","article-title":"Chronic oxytocin administration as a treatment against impaired leptin signaling or leptin resistance in obesity","volume":"6","author":"Altirriba","year":"2015","journal-title":"Front Endocrinol (Lausanne)"}],"container-title":["Physiology &amp; Behavior"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0031938418301318?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0031938418301318?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,10,12]],"date-time":"2019-10-12T09:18:22Z","timestamp":1570871902000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0031938418301318"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,5]]},"references-count":40,"alternative-id":["S0031938418301318"],"URL":"https:\/\/doi.org\/10.1016\/j.physbeh.2018.03.008","relation":{},"ISSN":["0031-9384"],"issn-type":[{"value":"0031-9384","type":"print"}],"subject":[],"published":{"date-parts":[[2018,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Effects of intranasal oxytocin on satiety signaling in people with schizophrenia","name":"articletitle","label":"Article Title"},{"value":"Physiology & Behavior","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.physbeh.2018.03.008","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}